Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Severe Vulvar Lichen Sclerosus
NCT07352917Phase 2Recruiting
- Sponsor
- Clinica Dermatologica Arbache
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in vulvar lichen sclerosus (LS), sponsored by Clinica Dermatologica Arbache. Started Jan 2026; status: recruiting.
02
Drugs
methotrexate
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT07352917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07352917.